1. Search Result

Search Result

Results for "179324-69-7" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-10227

    PS-341; LDP-341; NSC 681239

    Proteasome Apoptosis Autophagy Cancer
    Bortezomib (PS-341) is a cell-permeable, reversible, and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0.6 nM) by targeting a threonine residue. Bortezomib (PS-341) disrupts the cell cycle, induces apoptosis, and inhibits NF-κB. Bortezomib (PS-341) is an anti-cancer drug and the first therapeutic proteasome inhibitor to be used in humans.